Skip to main content

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Zimmer Hip Implant Lawsuit Dismissed Over Late Filing

Introduction

U.S. District Judge Edward G. Smith dismissed a plaintiff's claims over defective Zimmer prosthetic hip implant stating she failed to file the case within the two-year statute of limitations.

The plaintiff underwent total hip surgery in 2011 when she was implanted with Zimmer M/L Taper Kinectiv Stem and Neck (the “Kinectiv”) with a Versys Femoral Head (the “Versys Head”), collectively referred to as Zimmer Device. She eventually got it removed in 2015 after experiencing metallosis, which is an adverse local tissue reaction allegedly due to the implant. She filed a lawsuit in February 2017 against the hip implant maker. The Pennsylvania jury stated that she was late by just a few days in filing the case.

Zimmer lawsuits filed across the U.S. claim that the Zimmer M/L Taper Hip Prosthesis and Zimmer VerSys Hip femoral head are defectively designed,  pose major health risks when paired together, and have a tendency to corrode and leave metal pieces inside the body often needing the device to be removed.

Zimmer Durom Hip Cup lawsuits were centralized on June 9, 2010, in the U.S District of New Jersey before Judge Susan D. Wigenton as multidistrict litigation, MDL No. 2158 (In Re: Zimmer Durom Hip Cup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!